Explain visually
Reading File
Searching Images
aminoglycoside mechanism of action bacterial protein synthesis ribosome
Searching Images
aminoglycoside transport bacterial cell wall membrane penetration
Loading Image
Generating Image
Here is a full visual explanation of the content from that page โ Chapter 54: Aminoglycoside Antibiotics.
๐ฌ Mechanism of Action โ Visual Breakdown
Step 1: Penetration into the Bacterial Cell
How the drug gets in:
| Stage | What Happens |
|---|---|
| Outer membrane | Drug diffuses through porin channels (passive, no energy needed) |
| Periplasmic space | Drug accumulates, waiting to cross the inner membrane |
| Cytoplasmic membrane | Crossed via carrier-mediated, energy-dependent transport โ requires a polarized membrane and the electron transport chain (called EDPโ entry) |
This is why aminoglycosides don't work on anaerobes โ no active electron transport chain = no drug entry.
Step 2: Ribosomal Binding & Protein Synthesis Inhibition
The diagram below shows the three ways aminoglycosides attack the 30S ribosomal subunit:
Focus on panel 2 (aminoglycosides, green bars):
| Effect | Result |
|---|---|
| (A) Block initiation | The 30S + 50S ribosome complex cannot form properly |
| (B) Inhibit tRNA translocation | tRNA cannot move from A-site โ P-site; elongation stalls |
| (C) mRNA misreading | Incorrect amino acids are incorporated โ faulty/non-functional proteins |
The Self-Amplifying Cycle (Key Concept!)
The faulty membrane proteins produced by misreading insert back into the bacterial membrane, making it more permeable. This lets even more aminoglycoside rush in โ creating a self-reinforcing bactericidal loop. This explains why aminoglycosides are concentration-dependent and bactericidal, not just bacteriostatic.
๐งช Common Properties at a Glance
| Property | Clinical Implication |
|---|---|
| Sulfate salts, highly water-soluble | Stable in solution for months |
| Not absorbed orally | Must be given parenterally (IM/IV) for systemic infections |
| Excreted unchanged by glomerular filtration | Dose adjustment required in renal failure |
| More active at alkaline pH | Less effective inside acidic abscesses |
| Active against aerobic gram-negatives only | No activity against anaerobes or penetrating CSF |
| Ototoxicity & nephrotoxicity | Major dose-limiting toxicities; monitor drug levels |
| Narrow safety margin | Requires therapeutic drug monitoring (TDM) |
๐ Drug List Summary
Systemic: Streptomycin, Gentamicin, Kanamycin, Tobramycin, Amikacin, Sisomicin, Netilmicin, Paromomycin
Topical only: Neomycin, Framycetin (too toxic for systemic use)
Historical note: Streptomycin (1944) was the first โ critically important as the first effective drug against tuberculosis, discovered by Waksman via deliberate soil actinomycete screening.
This is a shared conversation. Sign in to Orris to start your own chat.